Skip to main content

Model based drug development (MBDD) of pegylated growth hormone (PEG-hGH) in the treatment of adult growth hormone deficiency (AGHD)

Xie, Rujia, Higgins, Tracy, Mandama, Jaap (2008) Model based drug development (MBDD) of pegylated growth hormone (PEG-hGH) in the treatment of adult growth hormone deficiency (AGHD). In: PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe. . (Unpublished) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)
Official URL
http://www.page-meeting.org/?abstract=1295

Abstract

Objectives: This presentation reviews the major MBDD activities and their influence on the early development of PEG-hGH and the inception of an expedited late development strategy.

Item Type: Conference or workshop item (Paper)
Additional information: Unpublished Pfizer report
Subjects: R Medicine > R Medicine (General)
R Medicine > RS Pharmacy and materia medica
Divisions: Faculties > Social Sciences > School of Social Policy Sociology and Social Research > Centre for Health Services Studies
Depositing User: Tracy Pellatt-Higgins
Date Deposited: 03 Jan 2014 10:44 UTC
Last Modified: 29 May 2019 11:42 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/37707 (The current URI for this page, for reference purposes)
  • Depositors only (login required):